In addition, increased MyD88 and p-NFκB were inhibited in AD-TLR2KO mice, indicating that, in the late stage of AD, the activation of MyD88-dependent signaling is mediated through TLR2. The gene discussed is TLR2; the disease is Alzheimer disease.